Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO

Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
Drug Metabolism and Disposition June 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
Miia Turpeinen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riina Nieminen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tarja Juntunen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Päivi Taavitsainen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hannu Raunio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olavi Pelkonen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 6 626-631
DOI 
https://doi.org/10.1124/dmd.32.6.626
PubMed 
15155554

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received November 5, 2003
  • Accepted February 23, 2004
  • Published online May 20, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Miia Turpeinen,
  2. Riina Nieminen,
  3. Tarja Juntunen,
  4. Päivi Taavitsainen1,
  5. Hannu Raunio and
  6. Olavi Pelkonen
  1. Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland (M.T., R.N., T.J., P.T., O.P.); and Department of Pharmacology and Toxicology, University of Kuopio, Kuopio, Finland (R.N., H.R.)
  1. Address correspondence to:
    Miia Turpeinen, Department of Pharmacology and Toxicology, P.O. Box 5000, 90014 University of Oulu, Oulun Yliopisto, Finland. E-mail: mturpein{at}paju.oulu.fi
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to March 2023

AbstractFullPdf
Aug 201724116
Sep 201723916
Oct 201744624
Nov 201746126
Dec 201723016
Jan 201854315
Feb 201883828
Mar 201833114
Apr 20186368
May 201862618
Jun 20185279
Jul 201832316
Aug 201843119
Sep 20181216
Oct 201822813
Nov 201815412
Dec 201854166
Jan 201985107
Feb 20196524
Mar 20192585
Apr 20193320
May 20191343
Jun 20192022
Jul 20192644
Aug 20193243
Oct 20192032
Nov 20192401
Dec 20193673
Jan 20204312
Feb 20202551
Mar 20201941
May 20201610
Jun 20202013
Jul 20201613
Aug 20201333
Sep 20202651
Oct 20202642
Nov 20201512
Dec 20203351
Jan 202116232
Feb 202122143
Mar 20213046
Apr 20211823
May 202150116
Jun 202160128
Jul 20213463
Aug 202140135
Sep 20211384
Oct 20211941
Nov 20212461
Dec 20212752
Jan 20221742
Feb 20221322
Mar 20224122
Apr 20223192
May 20222221
Jun 20223932
Jul 20222121
Aug 20221742
Sep 20222684
Oct 202227123
Nov 20223233
Dec 20222311
Jan 20234771
Feb 20234763
Mar 20231820

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (6)
Drug Metabolism and Disposition
Vol. 32, Issue 6
1 Jun 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO

Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
Drug Metabolism and Disposition June 1, 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO

Miia Turpeinen, Riina Nieminen, Tarja Juntunen, Päivi Taavitsainen, Hannu Raunio and Olavi Pelkonen
Drug Metabolism and Disposition June 1, 2004, 32 (6) 626-631; DOI: https://doi.org/10.1124/dmd.32.6.626
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Metabolic enzymes in nintedanib metabolism
  • Mechanism of AO Inactivation by Hydralazine
  • Warfarin PBPK modeling with target binding
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics